Literature DB >> 1494510

Mycobacteria as a cause of infective exacerbation in bronchiectasis.

C H Chan1, A K Ho, R C Chan, H Cheung, A F Cheng.   

Abstract

In 91 patients with bronchiectasis seen over 6 years, a positive mycobacterial culture was obtained in 12 cases (13%). The organisms isolated were Mycobacterium tuberculosis in nine cases, Mycobacterium avium in two cases and Mycobacterium tuberculosis and chelonei were obtained on separate occasions in one case. Computed tomography and/or bronchography showed that the bronchiectatic changes commonly involved the lower lobes and to a lesser extent, the middle and lingula lobes. In none of these 12 cases was tuberculosis strongly suspected on clinical or radiological grounds. We conclude that mycobacterial infections are common in patients with bronchiectasis and sputum should be cultured for mycobacteria periodically in these patients. In doubtful cases, bronchoscopy may be helpful to obtain a positive mycobacterial culture.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494510      PMCID: PMC2399483          DOI: 10.1136/pgmj.68.805.896

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  13 in total

1.  A study of the pathology and pathogenesis of bronchiectasis.

Authors:  F WHITWELL
Journal:  Thorax       Date:  1952-09       Impact factor: 9.139

2.  Bronchoscopic aspiration and bronchoalveolar lavage in the diagnosis of sputum smear-negative pulmonary tuberculosis.

Authors:  H S Chan; A J Sun; G B Hoheisel
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  The immunological component of the cellular inflammatory infiltrate in bronchiectasis.

Authors:  J R Silva; J A Jones; P J Cole; L W Poulter
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

Review 4.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

5.  A study of pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: clinical characteristics. XX. A report of the Veterans Administration-armed forces cooperative study on the chemotherapy of tuberculosis.

Authors:  J H Bates
Journal:  Am Rev Respir Dis       Date:  1967-12

Review 6.  Bronchiectasis: update of an orphan disease.

Authors:  A F Barker; E J Bardana
Journal:  Am Rev Respir Dis       Date:  1988-04

7.  The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage.

Authors:  J A Pang; A Cheng; H S Chan; D Poon; G French
Journal:  Am Rev Respir Dis       Date:  1989-01

8.  Mycobacterial isolations in young adults with cystic fibrosis.

Authors:  M J Smith; J Efthimiou; M E Hodson; J C Batten
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

9.  Expanding spectrum of pulmonary disease caused by nontuberculous mycobacteria.

Authors:  S M Albelda; J A Kern; D L Marinelli; W T Miller
Journal:  Radiology       Date:  1985-11       Impact factor: 11.105

10.  The value of computed tomography in the diagnosis and management of bronchiectasis.

Authors:  J A Pang; C Hamilton-Wood; C Metreweli
Journal:  Clin Radiol       Date:  1989-01       Impact factor: 2.350

View more
  6 in total

1.  Lobar distribution in non-cystic fibrosis bronchiectasis predicts bacteriologic pathogen treatment.

Authors:  S Izhakian; W G Wasser; L Fuks; B Vainshelboim; B D Fox; O Fruchter; M R Kramer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

2.  Impact of different etiologies of bronchiectasis on the pulmonary function tests.

Authors:  Agnaldo José Lopes; Gustavo Bittencourt Camilo; Sara Lucia Silveira de Menezes; Fernando Silva Guimarães
Journal:  Clin Med Res       Date:  2014-11-07

3.  Non-tuberculous mycobacteria in patients with bronchiectasis.

Authors:  M Wickremasinghe; L J Ozerovitch; G Davies; T Wodehouse; M V Chadwick; S Abdallah; P Shah; R Wilson
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

Review 4.  Severe bronchiectasis.

Authors:  Brian M Morrissey; Samuel J Evans
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

5.  Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.

Authors:  Shoghag Khoudigian-Sinani; Stacey Kowal; Jason A Suggett; Dominic P Coppolo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-19

6.  Bronchiectasis: a bacteriological profile.

Authors:  Régis Gothard Bopaka; Wiam El Khattabi; Hind Janah; Hasna Jabri; Hicham Afif
Journal:  Pan Afr Med J       Date:  2015-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.